Chronic Lymphocytic Leukemia: A Review of Front-Line Treatment Options, With a Focus on Elderly CLL Patients

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2018.02.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Analysis of Treatment Options for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Consolidation Treatment With Lenalidomide Following Front-Line or Salvage Chemoimmunotherapy in Chronic Lymphocytic Leukemia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2017English

Mp12: Cryoglobulinemia in a Patient With Chronic Lymphocytic Leukemia (Cll)– A Case Report and Review of Literature of Renal Involvement in CLL

Journal of Investigative Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Disease Burden of Chemotherapy and Chemoimmunotherapy Treatment of Chronic Lymphocytic Leukemia（CLL）Patients in China

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

DNA Methylation Signatures in Chronic Lymphocytic Leukemia (CLL)

Science-Business eXchange
2012English

First-Line Treatment of Chronic Lymphocytic Leukemia: Role of Alemtuzumab

OncoTargets and Therapy
OncologyPharmacology
2010English

Cd160 Expression in B Chronic Lymphocytic Leukemia (B-Cll.).

International Journal of Advanced Research
2017English

Chlorambucil Plus Rituximab as Front-Line Therapy for Elderly and/or Unfit Chronic Lymphocytic Leukemia Patients: Correlation With Biologically-Based Risk Stratification

Haematologica
Hematology
2017English

VENETOCLAX IN TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (Literature Review)

Oncogematologiya
OncologyHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy